SLSN SOLESENCE, INC.
Company Analysis
Latest News
Solesence to Restate Financials from 2023-2026 Due to Inventory Accounting Errors
Solésence, Inc. (SLSN) announced that its previously issued financial statements for multiple periods should no longer be relied upon due to significant...
Solésence's second quarter 2026 revenue fell 25% to $15.3M amid inventory accounting restatement
Solésence reported a 25% revenue decline for the second quarter 2026, generating $15.3 million as results normalized following a significant product launch in...
Solesence, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 19, 2026
Solesence, Inc. is scheduled to report its Q2 2026 financial results on August 19, 2026, though no formal Wall Street consensus revenue or EPS estimates exist...
Solesence, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 11, 2026
Solesence, Inc. is expected to report Q2 2026 revenue of $14.6 million and breakeven earnings per share of $0.00, with its current $1.07 stock price reflecting...
Solesence, Inc. Q2 2026 Earnings Preview: What Analysts Expect on July 30, 2026
Solesence, Inc. (SLSN) enters its Q2 2026 report with no formal analyst consensus for revenue or EPS, though management's full-year guidance suggests a...
Solésence Reaches $938,000 Settlement Agreement with Refy Beauty Ltd.
Solésence, Inc.'s wholly owned subsidiary, Solésence, LLC, entered into a settlement agreement with Refy Beauty Ltd on July 6, 2026, to resolve disputes over...